SIGNAL DETECTION & MANAGEMENT
We will be looking at the latest technology being used to pick up adverse events in an increasingly globalised market.
Exploring case studies across different companies to mitigate risk within PV.
BIG DATA, AUTOMATION AND AI IN SAFETY
A key area being explored in the field to enhance work processes through automation, such as interpretation, identification and prediction, for optimum efficiency.
SAFETY IN ONCOLOGY
A therapy specific track looking at the drug safety surrounding oncology.
Learning to work alongside vendors to be able to successfully outsource; lightening the load and increasing efficiency.
SAFETY IN ADVANCES THERAPIES
Looking at safety around new drugs and approaches that use stem cells, genes and tissues.
SAFETY & LABELLING
Presenting the differences around the world in label regulations and ways to improve problems within the field.
Addressing the ability to monitor reports on vaccine adverse reactions with signalling and RWE.
An international look around the world in to pharmacovigilance regulation and requirements.
REAL WORLD EVIDENCE AND RSI
Learning to use data from the market for risk minimilisation.
DS IN BIOSIMILAR & BIOLOGICS
Blockbuster biologics are coming off patent - we will be looking into how we can provide adequate safety for their biosimilars and the differences in the pharmacovigilance process.
PV IN EMERGING MARKETS
Applying what we know about drug safety to the emerging markets and what we can expect for the future.
Reducing strains on PV departments. Using next generation technologies to process adverse events cases in the most effective way possible.